Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 638

1.

The transcortical equatorial approach for gliomas of the mesial temporal lobe: techniques and functional outcomes.

Morshed RA, Young JS, Han SJ, Hervey-Jumper SL, Berger MS.

J Neurosurg. 2018 Apr 20:1-9. doi: 10.3171/2017.10.JNS172055. [Epub ahead of print]

PMID:
29676697
2.

Tuberculum sellae meningiomas: grading scale to assess surgical outcomes using the transcranial versus transsphenoidal approach.

Magill ST, Morshed RA, Lucas CG, Aghi MK, Theodosopoulos PV, Berger MS, de Divitiis O, Solari D, Cappabianca P, Cavallo LM, McDermott MW.

Neurosurg Focus. 2018 Apr;44(4):E9. doi: 10.3171/2018.1.FOCUS17753.

PMID:
29606045
3.

Comprehensive Molecular Profiling Identifies FOXM1 as a Key Transcription Factor for Meningioma Proliferation.

Vasudevan HN, Braunstein SE, Phillips JJ, Pekmezci M, Tomlin BA, Wu A, Reis GF, Magill ST, Zhang J, Feng FY, Nicholaides T, Chang SM, Sneed PK, McDermott MW, Berger MS, Perry A, Raleigh DR.

Cell Rep. 2018 Mar 27;22(13):3672-3683. doi: 10.1016/j.celrep.2018.03.013.

4.

Postoperative Delirium in Glioblastoma Patients: Risk Factors and Prognostic Implications.

Flanigan PM, Jahangiri A, Weinstein D, Dayani F, Chandra A, Kanungo I, Choi S, Sankaran S, Molinaro AM, McDermott MW, Berger MS, Aghi MK.

Neurosurgery. 2018 Feb 16. doi: 10.1093/neuros/nyx606. [Epub ahead of print]

PMID:
29462362
5.

Region specific knock-out reveals distinct roles of chromatin modifiers in adult neurogenic niches.

Rhodes CT, Zunino G, Huang SA, Cardona SM, Cardona AE, Berger MS, Lemmon VP, Lin CA.

Cell Cycle. 2018;17(3):377-389. doi: 10.1080/15384101.2018.1426417. Epub 2018 Feb 19.

PMID:
29433384
6.

Antisecretory Factor-Mediated Inhibition of Cell Volume Dynamics Produces Antitumor Activity in Glioblastoma.

Ilkhanizadeh S, Sabelström H, Miroshnikova YA, Frantz A, Zhu W, Idilli A, Lakins JN, Schmidt C, Quigley DA, Fenster T, Yuan E, Trzeciak JR, Saxena S, Lindberg OR, Mouw JK, Burdick JA, Magnitsky S, Berger MS, Phillips JJ, Arosio D, Sun D, Weaver VM, Weiss WA, Persson AI.

Mol Cancer Res. 2018 Feb 5. doi: 10.1158/1541-7786.MCR-17-0413. [Epub ahead of print]

PMID:
29431617
7.

Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment.

Wang Q, Hu B, Hu X, Kim H, Squatrito M, Scarpace L, deCarvalho AC, Lyu S, Li P, Li Y, Barthel F, Cho HJ, Lin YH, Satani N, Martinez-Ledesma E, Zheng S, Chang E, Gabriel Sauvé CE, Olar A, Lan ZD, Finocchiaro G, Phillips JJ, Berger MS, Gabrusiewicz KR, Wang G, Eskilsson E, Hu J, Mikkelsen T, DePinho RA, Muller F, Heimberger AB, Sulman EP, Nam DH, Verhaak RGW.

Cancer Cell. 2018 Jan 8;33(1):152. doi: 10.1016/j.ccell.2017.12.012. No abstract available.

8.

A cross-sectional study of neurosurgical department chairs in the United States.

Flanigan PM, Jahangiri A, Golubovsky JL, Karnuta JM, May FJ, Berger MS, Aghi MK.

J Neurosurg. 2018 Jan 5:1-7. doi: 10.3171/2017.7.JNS17567. [Epub ahead of print]

PMID:
29303441
9.

Resection of primary motor cortex tumors: feasibility and surgical outcomes.

Magill ST, Han SJ, Li J, Berger MS.

J Neurosurg. 2017 Dec 8:1-12. doi: 10.3171/2017.5.JNS163045. [Epub ahead of print]

PMID:
29219753
10.

Surgical oncology for gliomas: the state of the art.

Sanai N, Berger MS.

Nat Rev Clin Oncol. 2018 Feb;15(2):112-125. doi: 10.1038/nrclinonc.2017.171. Epub 2017 Nov 21. Review.

PMID:
29158591
11.

Seizure Outcome After Surgical Resection of Insular Glioma.

Wang DD, Deng H, Hervey-Jumper SL, Molinaro AA, Chang EF, Berger MS.

Neurosurgery. 2017 Nov 8. doi: 10.1093/neuros/nyx486. [Epub ahead of print]

PMID:
29126238
12.

Resection of gliomas deemed inoperable by neurosurgeons based on preoperative imaging studies.

Southwell DG, Birk HS, Han SJ, Li J, Sall JW, Berger MS.

J Neurosurg. 2017 Nov 10:1-9. doi: 10.3171/2017.5.JNS17166. [Epub ahead of print]

PMID:
29125414
13.

Prospective Feasibility Trial for Genomics-Informed Treatment in Recurrent and Progressive Glioblastoma.

Byron SA, Tran NL, Halperin RF, Phillips JJ, Kuhn JG, de Groot JF, Colman H, Ligon KL, Wen PY, Cloughesy TF, Mellinghoff IK, Butowski NA, Taylor JW, Clarke JL, Chang SM, Berger MS, Molinaro AM, Maggiora GM, Peng S, Nasser S, Liang WS, Trent JM, Berens ME, Carpten JD, Craig DW, Prados MD.

Clin Cancer Res. 2018 Jan 15;24(2):295-305. doi: 10.1158/1078-0432.CCR-17-0963. Epub 2017 Oct 26.

PMID:
29074604
14.

Connected speech in transient aphasias after left hemisphere resective surgery.

McCarron A, Chavez A, Babiak M, Berger MS, Chang EF, Wilson SM.

Aphasiology. 2017;31(11):1266-1281. doi: 10.1080/02687038.2017.1278740. Epub 2017 Jan 17.

15.

In Reply: Neurosurgical Education in a Changing Healthcare and Regulatory Environment: A Consensus Statement From 6 Programs.

Kim DH, Dacey RG, Zipfel GJ, Berger MS, McDermott M, Barbaro NM, Shapiro SA, Solomon RA, Harbaugh R, Day AL.

Neurosurgery. 2017 Oct 1;81(4):E47. doi: 10.1093/neuros/nyx348. No abstract available.

PMID:
28934443
16.

Management of Elderly Patients with Glioblastoma after CE.6.

Das S, Kim AH, Chang S, Berger MS.

Front Oncol. 2017 Aug 30;7:196. doi: 10.3389/fonc.2017.00196. eCollection 2017. No abstract available.

17.

Changing Operating Room Culture: Implementation of a Postoperative Debrief and Improved Safety Culture.

Magill ST, Wang DD, Rutledge WC, Lau D, Berger MS, Sankaran S, Lau CY, Imershein SG.

World Neurosurg. 2017 Nov;107:597-603. doi: 10.1016/j.wneu.2017.08.090. Epub 2017 Aug 24.

PMID:
28843757
18.

Adaptive Global Innovative Learning Environment for Glioblastoma: GBM AGILE.

Alexander BM, Ba S, Berger MS, Berry DA, Cavenee WK, Chang SM, Cloughesy TF, Jiang T, Khasraw M, Li W, Mittman R, Poste GH, Wen PY, Yung WKA, Barker AD; GBM AGILE Network.

Clin Cancer Res. 2018 Feb 15;24(4):737-743. doi: 10.1158/1078-0432.CCR-17-0764. Epub 2017 Aug 16. Review.

PMID:
28814435
19.

Intraoperative perception and estimates on extent of resection during awake glioma surgery: overcoming the learning curve.

Lau D, Hervey-Jumper SL, Han SJ, Berger MS.

J Neurosurg. 2017 Jul 21:1-9. doi: 10.3171/2017.1.JNS161811. [Epub ahead of print]

PMID:
28731401
20.

Familial melanoma-astrocytoma syndrome: synchronous diffuse astrocytoma and pleomorphic xanthoastrocytoma in a patient with germline CDKN2A/B deletion and a significant family history.

Chan AK, Han SJ, Choy W, Beleford D, Aghi MK, Berger MS, Shieh JT, Bollen AW, Perry A, Phillips JJ, Butowski N, Solomon DA.

Clin Neuropathol. 2017 Sep/Oct;36(5):213-221. doi: 10.5414/NP301022.

21.

Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment.

Wang Q, Hu B, Hu X, Kim H, Squatrito M, Scarpace L, deCarvalho AC, Lyu S, Li P, Li Y, Barthel F, Cho HJ, Lin YH, Satani N, Martinez-Ledesma E, Zheng S, Chang E, Sauvé CG, Olar A, Lan ZD, Finocchiaro G, Phillips JJ, Berger MS, Gabrusiewicz KR, Wang G, Eskilsson E, Hu J, Mikkelsen T, DePinho RA, Muller F, Heimberger AB, Sulman EP, Nam DH, Verhaak RGW.

Cancer Cell. 2017 Jul 10;32(1):42-56.e6. doi: 10.1016/j.ccell.2017.06.003. Erratum in: Cancer Cell. 2018 Jan 8;33(1):152.

PMID:
28697342
22.

Wavelength-specific lighted suction instrument for 5-aminolevulinic acid fluorescence-guided resection of deep-seated malignant glioma: technical note.

Morshed RA, Han SJ, Lau D, Berger MS.

J Neurosurg. 2017 Jun 30:1-6. doi: 10.3171/2017.1.JNS161949. [Epub ahead of print]

PMID:
28665248
23.

Improved Survival with Decreased Wait Time to Surgery in Glioblastoma Patients Presenting with Seizure.

Flanigan PM, Jahangiri A, Kuang R, Truong A, Choi S, Chou A, Rick JW, Chang SM, Molinaro AM, McDermott MW, Berger MS, Aghi MK.

Neurosurgery. 2017 Nov 1;81(5):824-833. doi: 10.1093/neuros/nyx084.

PMID:
28541497
24.

Diffuse non-midline glioma with H3F3A K27M mutation: a prognostic and treatment dilemma.

López G, Oberheim Bush NA, Berger MS, Perry A, Solomon DA.

Acta Neuropathol Commun. 2017 May 15;5(1):38. doi: 10.1186/s40478-017-0440-x. No abstract available.

25.

Developing an Algorithm for Optimizing Care of Elderly Patients With Glioblastoma.

Flanigan PM, Jahangiri A, Kuang R, Truong A, Choi S, Chou A, Molinaro AM, McDermott MW, Berger MS, Aghi MK.

Neurosurgery. 2018 Jan 1;82(1):64-75. doi: 10.1093/neuros/nyx148.

PMID:
28475720
26.

Analysis of Cost Variation in Craniotomy for Tumor Using 2 National Databases.

Zygourakis CC, Liu CY, Yoon S, Moriates C, Boscardin C, Dudley RA, Lawton MT, Theodosopoulos P, Berger MS, Gonzales R.

Neurosurgery. 2017 Dec 1;81(6):972-979. doi: 10.1093/neuros/nyx133.

PMID:
28402457
27.

A Review and Survey of Neurosurgeon-Hospital Relationships: Evolution and Options.

Kim DH, Duco B, Wolterman D, Stokes C, Brace R, Solomon RA, Barbaro N, Westmark R, MacDougall D, Bean J, O'Leary J, Moayeri N, Dacey RG Jr, Berger MS, Harbaugh R.

Neurosurgery. 2017 Apr 1;80(4S):S10-S18. doi: 10.1093/neuros/nyw171. Review.

PMID:
28375496
28.

Metabolic Profiling of IDH Mutation and Malignant Progression in Infiltrating Glioma.

Jalbert LE, Elkhaled A, Phillips JJ, Neill E, Williams A, Crane JC, Olson MP, Molinaro AM, Berger MS, Kurhanewicz J, Ronen SM, Chang SM, Nelson SJ.

Sci Rep. 2017 Mar 22;7:44792. doi: 10.1038/srep44792.

29.

Comparative analyses identify molecular signature of MRI-classified SVZ-associated glioblastoma.

Lin CA, Rhodes CT, Lin C, Phillips JJ, Berger MS.

Cell Cycle. 2017 Apr 18;16(8):765-775. doi: 10.1080/15384101.2017.1295186. Epub 2017 Feb 22.

30.

Foreword.

Berger MS.

Neurochirurgie. 2017 Jun;63(3):113-114. doi: 10.1016/j.neuchi.2016.05.003. Epub 2016 Oct 26. No abstract available.

PMID:
28277279
31.

Adult infiltrating gliomas with WHO 2016 integrated diagnosis: additional prognostic roles of ATRX and TERT.

Pekmezci M, Rice T, Molinaro AM, Walsh KM, Decker PA, Hansen H, Sicotte H, Kollmeyer TM, McCoy LS, Sarkar G, Perry A, Giannini C, Tihan T, Berger MS, Wiemels JL, Bracci PM, Eckel-Passow JE, Lachance DH, Clarke J, Taylor JW, Luks T, Wiencke JK, Jenkins RB, Wrensch MR.

Acta Neuropathol. 2017 Jun;133(6):1001-1016. doi: 10.1007/s00401-017-1690-1. Epub 2017 Mar 2.

PMID:
28255664
32.

Neurosurgical Education in a Changing Healthcare and Regulatory Environment: A Consensus Statement from 6 Programs.

Kim DH, Dacey RG, Zipfel GJ, Berger MS, McDermott M, Barbaro NM, Shapiro SA, Solomon RA, Harbaugh R, Day AL.

Neurosurgery. 2017 Apr 1;80(4S):S75-S82. doi: 10.1093/neuros/nyw146.

PMID:
28204661
33.

Anesthesia for awake craniotomy: a how-to guide for the occasional practitioner.

Meng L, McDonagh DL, Berger MS, Gelb AW.

Can J Anaesth. 2017 May;64(5):517-529. doi: 10.1007/s12630-017-0840-1. Epub 2017 Feb 8. Review.

PMID:
28181184
34.

Language outcomes after resection of dominant inferior parietal lobule gliomas.

Southwell DG, Riva M, Jordan K, Caverzasi E, Li J, Perry DW, Henry RG, Berger MS.

J Neurosurg. 2017 Oct;127(4):781-789. doi: 10.3171/2016.8.JNS16443. Epub 2017 Jan 6.

PMID:
28059657
35.

Erratum to: Surgical resection of fourth ventricular ependymomas: case series and technical nuances.

Winkler EA, Birk H, Safaee M, Yue JK, Burke JF, Viner JA, Pekmezci M, Perry A, Aghi MK, Berger MS, McDermott MW.

J Neurooncol. 2017 Jan;131(2):423. doi: 10.1007/s11060-016-2343-2. No abstract available.

PMID:
28039568
36.

Epigenetic Activation of WNT5A Drives Glioblastoma Stem Cell Differentiation and Invasive Growth.

Hu B, Wang Q, Wang YA, Hua S, Sauvé CG, Ong D, Lan ZD, Chang Q, Ho YW, Monasterio MM, Lu X, Zhong Y, Zhang J, Deng P, Tan Z, Wang G, Liao WT, Corley LJ, Yan H, Zhang J, You Y, Liu N, Cai L, Finocchiaro G, Phillips JJ, Berger MS, Spring DJ, Hu J, Sulman EP, Fuller GN, Chin L, Verhaak RGW, DePinho RA.

Cell. 2016 Nov 17;167(5):1281-1295.e18. doi: 10.1016/j.cell.2016.10.039.

37.

Surgical resection of fourth ventricular ependymomas: case series and technical nuances.

Winkler EA, Birk H, Safaee M, Yue JK, Burke JF, Viner JA, Pekmezci M, Perry A, Aghi MK, Berger MS, McDermott MW.

J Neurooncol. 2016 Nov;130(2):341-349. Epub 2016 Oct 24. Review. Erratum in: J Neurooncol. 2017 Jan;131(2):423.

PMID:
27778210
38.

The transsylvian approach for resection of insular gliomas: technical nuances of splitting the Sylvian fissure.

Safaee MM, Englot DJ, Han SJ, Lawton MT, Berger MS.

J Neurooncol. 2016 Nov;130(2):283-287. Epub 2016 Jun 13. Review.

PMID:
27294356
39.

BRAF Status in Personalizing Treatment Approaches for Pediatric Gliomas.

Olow A, Mueller S, Yang X, Hashizume R, Meyerowitz J, Weiss W, Resnick AC, Waanders AJ, Stalpers LJ, Berger MS, Gupta N, James CD, Petritsch CK, Haas-Kogan DA.

Clin Cancer Res. 2016 Nov 1;22(21):5312-5321. Epub 2016 May 23.

40.

Maximizing safe resection of low- and high-grade glioma.

Hervey-Jumper SL, Berger MS.

J Neurooncol. 2016 Nov;130(2):269-282. Epub 2016 May 12. Review.

PMID:
27174197
41.

Concurrent MEK targeted therapy prevents MAPK pathway reactivation during BRAFV600E targeted inhibition in a novel syngeneic murine glioma model.

Grossauer S, Koeck K, Murphy NE, Meyers ID, Daynac M, Truffaux N, Truong AY, Nicolaides TP, McMahon M, Berger MS, Phillips JJ, James CD, Petritsch CK.

Oncotarget. 2016 Nov 15;7(46):75839-75853. doi: 10.18632/oncotarget.12419.

42.

Meeting the Unmet Need: Training General Surgeons to Perform Life-Saving Neurosurgical Procedures in Low-Resource Settings.

Griswold D, Benet A, Berger MS, Lawton MT.

World Neurosurg. 2016 Sep;93:474. doi: 10.1016/j.wneu.2016.06.044. No abstract available.

PMID:
27637695
43.

Expression and prognostic impact of immune modulatory molecule PD-L1 in meningioma.

Han SJ, Reis G, Kohanbash G, Shrivastav S, Magill ST, Molinaro AM, McDermott MW, Theodosopoulos PV, Aghi MK, Berger MS, Butowski NA, Barani I, Phillips JJ, Perry A, Okada H.

J Neurooncol. 2016 Dec;130(3):543-552. Epub 2016 Sep 13.

44.

Chemotherapy for adult low-grade gliomas: clinical outcomes by molecular subtype in a phase II study of adjuvant temozolomide.

Wahl M, Phillips JJ, Molinaro AM, Lin Y, Perry A, Haas-Kogan DA, Costello JF, Dayal M, Butowski N, Clarke JL, Prados M, Nelson S, Berger MS, Chang SM.

Neuro Oncol. 2017 Feb 1;19(2):242-251. doi: 10.1093/neuonc/now176.

45.

Prioritization schema for immunotherapy clinical trials in glioblastoma.

Hodges TR, Ferguson SD, Caruso HG, Kohanbash G, Zhou S, Cloughesy TF, Berger MS, Poste GH, Khasraw M, Ba S, Jiang T, Mikkelson T, Yung WK, de Groot JF, Fine H, Cantley LC, Mellinghoff IK, Mitchell DA, Okada H, Heimberger AB.

Oncoimmunology. 2016 Feb 18;5(6):e1145332. doi: 10.1080/2162402X.2016.1145332. eCollection 2016 Jun. Review.

46.

The Development of Reduced Diffusion Following Bevacizumab Therapy Identifies Regions of Recurrent Disease in Patients with High-grade Glioma.

Barajas RF Jr, Butowski NA, Phillips JJ, Aghi MK, Berger MS, Chang SM, Cha S.

Acad Radiol. 2016 Sep;23(9):1073-82. doi: 10.1016/j.acra.2016.04.004. Epub 2016 Jul 18.

47.

Cross-species Analyses Unravel the Complexity of H3K27me3 and H4K20me3 in the Context of Neural Stem Progenitor Cells.

Rhodes CT, Sandstrom RS, Huang SA, Wang Y, Schotta G, Berger MS, Lin CA.

Neuroepigenetics. 2016 Jun;6:10-25. Epub 2016 May 3.

48.

Indications and Efficacy of Gamma Knife Stereotactic Radiosurgery for Recurrent Glioblastoma: 2 Decades of Institutional Experience.

Imber BS, Kanungo I, Braunstein S, Barani IJ, Fogh SE, Nakamura JL, Berger MS, Chang EF, Molinaro AM, Cabrera JR, McDermott MW, Sneed PK, Aghi MK.

Neurosurgery. 2017 Jan 1;80(1):129-139. doi: 10.1227/NEU.0000000000001344.

49.

Laser Ablation vs Open Resection for Deep-Seated Tumors: The Case for Open Resection.

Han SJ, Chang SM, Berger MS.

Neurosurgery. 2016 Aug;63 Suppl 1:10-14. doi: 10.1227/NEU.0000000000001288. No abstract available.

PMID:
27399358
50.

Resection and brain brachytherapy with permanent iodine-125 sources for brain metastasis.

Raleigh DR, Seymour ZA, Tomlin B, Theodosopoulos PV, Berger MS, Aghi MK, Geneser SE, Krishnamurthy D, Fogh SE, Sneed PK, McDermott MW.

J Neurosurg. 2017 Jun;126(6):1749-1755. doi: 10.3171/2016.4.JNS152530. Epub 2016 Jul 1.

PMID:
27367240

Supplemental Content

Loading ...
Support Center